Medical AI Measured Against the Clinical Standard — Including Where It Fails
In preprints, a thyroid model matches an established scoring system, a pathology model predicts cancer subtypes, ECG signals predict mortality, and a paired workflow steadies AI triage — each with a stated caveat.
- MedGemma 1.5 4B with structured radiologist descriptors is non-inferior to EU-TIRADS for thyroid nodule malignancy risk stratification, in a preprint. Self-reported m:…2115
- HERA predicts HPV/p16 status in vulvar squamous cell carcinoma with an AUC of 0.84 in independent testing of 286 patients, in a preprint. Self-reported m:…9865
- Synthetic e-prime velocity derived from 12-lead ECGs independently predicts all-cause mortality after acute myocardial infarction after adjusting for GRACE score, in a preprint. Self-reported m:…1422
- Pairing decision-only medical AI with language models cuts framing-induced decision volatility by about 81% in development and 42-48% in held-out reports, in a preprint. Self-reported m:…1744
- MedGemma's raw probability outputs are miscalibrated (ECE 0.117) and require Platt scaling for clinical use, in a preprint. Self-reported m:…2115
Thyroid nodules: matching the standard, cutting false positives
In a preprint from a Tunisian multicenter diagnostic accuracy study, a fine-tuned medical vision-language model, MedGemma 1.5 4B, combined with structured radiologist descriptors — the configuration called Config D — is non-inferior to EU-TIRADS for thyroid nodule malignancy risk stratification at ultrasound. Non-inferiority is the right bar here: the model is not being asked to beat the established scoring system, but to match it while changing something else about the workflow. m:…2115
The change it offers is fewer false alarms. Config D reclassified 72 of 205 benign nodules rated EU-TIRADS 4 as negative, reducing false positives. For patients, that is the difference between further workup and watchful waiting, and it is the kind of concrete benefit that justifies testing a model against a standard rather than against other models. The preprint is equally direct about the model's weakness: raw probability outputs from the fine-tuned model are miscalibrated, with an expected calibration error of 0.117, and require Platt scaling for clinical use. A model can rank cases correctly while still stating its confidence badly, and the authors say so plainly. m:…2115
Cancer slides: molecular subtypes from histopathology
A second diagnostics preprint applies deep learning to histopathology slides in vulvar squamous cell carcinoma. The model HERA achieved an area under the curve of 0.84, with a 95 percent confidence interval of 0.75 to 0.91, for predicting HPV/p16 status in independent testing of 286 patients. Predicting a molecular marker from a routine slide, rather than from a separate molecular test, is the practical prize: the information is already sitting in the pathology workflow. m:…9865
The companion model, HERMES, goes further, predicting molecular subtypes whose prognostic hierarchy the preprint reproduces: five-year recurrence rates of 14.0 percent for HPV-associated disease, 31.1 percent for HPV-independent and p53-wildtype disease, and 43.3 percent for HPV-independent and p53-abnormal disease. But the preprint also reports the limit. HERMES demonstrated limited separation of the two HPV-independent subtypes, with areas under the curve of 0.68 for the p53-abnormal subtype and 0.63 for the p53-wildtype subtype. The model separates the broad groups well and the hardest pair poorly, and any clinical use would have to live with that boundary. m:…9865
Heart signals: mortality risk hidden in an ECG
A third preprint finds prognostic signal in a routine test. Synthetic e-prime velocity derived from 12-lead ECGs is an independent predictor of all-cause mortality after acute myocardial infarction, after adjusting for GRACE score, the established risk tool. MAPSE derived from 12-lead ECGs is a significant predictor of myocardial-infarction-specific mortality in the general population, with a subdistribution hazard ratio of 0.49. The point of deriving left-ventricular mechanics from an ECG is reach: ECGs are far more available than the imaging that normally measures these quantities. m:…1422
The preprint adds that synthetic left-ventricular mechanical parameters provide incremental prognostic value over measured left-ventricular ejection fraction and over AI-ECG-predicted ejection fraction. Incremental value is the honest test for a new biomarker: it must add information beyond what clinicians already have, not merely repeat it in a new format. Here, the ECG-derived mechanics clear that bar in the preprint's analysis. m:…1422
Triage: pairing models to steady the decision
A fourth preprint addresses a different failure mode: framing. Decision-only models and language models exhibit significant framing sensitivity, with decision changes of 13.4 percent and 14.0 percent respectively when neutral wording is replaced by labels or pressure cues. A triage tool that changes its answer because of how a case is worded, rather than what the case contains, is a safety problem even if its average accuracy looks acceptable. m:…1744
Pairing decision-only models with language models reduces framing-induced decision volatility by approximately 81 percent in development and 42 to 48 percent in held-out reports, while the paired workflow maintains triage accuracy between 81 and 82 percent at a cost of 0.77 US dollars per 1,000 entries. The held-out figure is the one to weight: the benefit shrinks outside development data, but it does not vanish, and the cost figure gives buyers a concrete denominator. Across all four preprints, the pattern is the same — models judged against clinical standards, with their calibration, separation, and framing limits reported alongside their wins. m:…1744
What is still unresolved
- Whether MedGemma's calibration holds after Platt scaling in prospective clinical use.
- Whether HERMES subtype separation improves for the two HPV-independent subtypes.
- Whether paired triage workflows hold their accuracy and cost outside the studied reports.
Provenance by Synorb. Every claim links to its source. This story was written by an agent from the Manifests listed below. Read the methodology and limitations, or send a correction.
Free to reuse, including commercially. Credit “Hanging Context, with provenance by Synorb” and link to this story. Keep the cited Manifest ids. Reuse terms v1.